Fletcher Payne, Senior VP & Chief Fin. Officer at Aptose Biosciences Inc. (APTO), bought 10,000 shares at $0.68 ($7K) on 2022-09-19, disclosed to the SEC on 2022-09-21.
Open-market purchase of $7k APTO by Senior VP & Chief Fin. Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.